Patents
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
06/2011
06/22/2011CN102105459A 3,4-diarylpyrazoles as protein kinase inhibitors
06/22/2011CN101511826B Preparation and purification of mupirocin calcium
06/22/2011CN101115742B Heterocycle derivatives as histone deacetylase (hdac) inhibitors
06/21/2011CA2676898C Ketal amide compounds, methods of making, and applications
06/21/2011CA2507707C 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
06/21/2011CA2483303C Cinnamic acid amides
06/16/2011WO2011022679A3 Benzofuran cannabinoid compounds and related methods of use
06/16/2011WO2011021726A3 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
06/16/2011US20110144096 Treating various disorders using trkb agonists
06/15/2011EP2332912A1 Heteroarylaminosulfonylphenylderivates for use as sodium or calcium channel blockers in the treatment of pain
06/15/2011EP2331531A2 Therapeutic substituted pyrroles
06/15/2011EP2331520A1 Rosamine derivatives as agents for the treatment of cancer
06/15/2011EP2331518A1 New bradykinin b1 antagonists
06/15/2011EP2331516A1 Imine derivatives as cannabinoid receptor ligands
06/15/2011CN102099355A Phenyl and benzodioxinyl substituted indazoles derivatives
06/15/2011CN102099350A Novel herbicides
06/15/2011CN102093342A C-28 toosendanin carboxylic ester derivatives and synthesis method thereof as well as application of C-28 toosendanin carboxylic ester derivative in preparing plant source pesticide
06/14/2011US7960570 Small molecule inhibitors of rotamase enzyme activity
06/14/2011US7960393 Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2
06/14/2011CA2534921C Aminotriazole compounds useful as inhibitors of protein kinases
06/09/2011WO2011011721A9 Compounds, compositions and methods for protecting brain health in neurodegenerative disorders
06/09/2011US20110137025 Chemical framework compositions and methods of use
06/09/2011US20110136830 Chromenone derivatives
06/09/2011US20110136752 Novel antibiotics
06/08/2011EP2328883A1 Method for preparing nebivolol
06/08/2011CN1890224B 6-substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose)polymerase inhibitors
06/08/2011CN102089294A Novel herbicides
06/08/2011CN102089285A Therapeutic N-aryl or N-heteroaryl pyrazolidine and pyrazolidinone derivatives
06/08/2011CN101044139B Cyclopamine analogues and methods of use thereof
06/07/2011US7956219 Amino acid analogues
06/07/2011US7955664 Chroman compounds
06/03/2011WO2011064249A1 Synthesis of acetoxyacetaldehyde
06/02/2011US20110130479 Adhesion promoter compounds for oiled steel
06/01/2011EP2327701A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
06/01/2011EP2327683A1 Synthesis of acetoxyacetaldehyde
06/01/2011EP2326634A1 Chromene modulators of chemokine receptor activity
06/01/2011EP2326633A1 Compounds for the treatment of hepatitis c
06/01/2011CN1934103B Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
06/01/2011CN102083818A Substituted 1-(diazinyl) pyrazole-4-yl-acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
06/01/2011CN102083817A Compounds and compositions as ITPKB inhibitors
06/01/2011CN102083800A Heteroaryl compounds and uses thereof
06/01/2011CN102079745A Production method of silymarin
06/01/2011CN101481375B Andrographolide C15 substituted series derivatives and preparation thereof
06/01/2011CN101180293B Naphthalamide derivatives having antiproliferative activity
05/2011
05/31/2011US7951956 Benzoimidazole compound capable of inhibiting prostaglandin D synthetase
05/31/2011US7951940 Substituted indole compounds having NOS inhibitory activity
05/31/2011US7951822 1,3-dihydroisobenzofuran derivatives
05/31/2011US7951820 Triazole compounds useful as protein kinase inhibitors
05/26/2011US20110124887 Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidant activity
05/26/2011US20110124673 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
05/26/2011US20110124669 Modulators of Cellular Adhesion
05/26/2011US20110124625 Modulators of Cellular Adhesion
05/25/2011EP2324008A1 3,4-diarylpyrazoles as protein kinase inhibitors
05/25/2011EP2324007A1 Triazole derivatives and their use as nicotinic acetylcholine receptor modulators
05/25/2011EP2323993A2 2,6-diamino- pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
05/25/2011EP2323987A1 N-myristoyl transferase inhibitors
05/25/2011EP2094691B1 Method for purifying dianhydrides
05/25/2011EP2021335B1 Heterocyclic compounds as inhibitors of c-fms kinase
05/25/2011CN102070622A Method for preparing multidentate Mannich alkali ligand
05/25/2011CN101260105B Method for extracting silibinin
05/25/2011CN101027286B Indozolone derivatives as 11b-HSD1 inhibitors
05/19/2011WO2011058193A1 [1,5]-diazocin derivatives
05/19/2011WO2010111634A3 Renin inhibitors
05/19/2011US20110118344 Novel compound having inhibitory effect on lipase
05/19/2011US20110118260 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy group
05/19/2011US20110118250 Beta-secretase modulators and methods of use
05/19/2011US20110117649 Catalytic enantioselective synthesis of flavanones and chromanones
05/19/2011US20110114882 Polymerizable oxetane derivative
05/19/2011CA2779088A1 [1,5]-diazocin derivatives
05/18/2011EP2321278A2 PYRIDINYL MODULATORS OF y-SECRETASE
05/18/2011EP2321274A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors
05/18/2011EP2321259A2 New compounds for the treatment of cancer
05/18/2011EP1529053B1 Macrolide compounds endowed with antiinflammatory activity
05/18/2011CN102066364A Composition of flavanolignan and amino acid with improved water solubility
05/18/2011CN102066339A 2, 6-diamino- pyrimidin- 5-yl-carboxamides as SYK or JAK kinases inhibitors
05/18/2011CN102066322A Compound having NPY Y5 receptor antagonist activity
05/18/2011CN101282933B Novel NK1 and NK2 antagonists
05/17/2011CA2440726C Substituted benzofuran-2-carboxamides derivatives
05/12/2011WO2011056652A1 Imidazole derivatives as ido inhibitors
05/12/2011US20110112183 Oligomer-Bis-Chromonyl Compound Conjugates
05/12/2011US20110112142 Novel estrogen receptor ligands
05/12/2011US20110112071 Novel heterocyclidene acetamide derivative
05/12/2011US20110111162 Indolium compound and optical recording material containing the same
05/12/2011US20110110865 Chelatros, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri)
05/12/2011CA2778115A1 Imidazole derivatives as ido inhibitors
05/11/2011EP2318363A1 Heterocyclic derivatives as iap binding compounds
05/11/2011CN102056846A Catalytic asymetric hydrogenation
05/11/2011CN102050853A Method for preparing multiple plant flavones by using membrane separation technology
05/11/2011CN102050852A 2'-O-rhamnosyl swertisin, preparation of analogues thereof, and application thereof
05/11/2011CN102050818A Puerarin derivatives containing nitrate substituent groups and preparation method and medicinal application thereof
05/11/2011CN102050809A Chemokine-like factor 1 (CKLF1)/C chemokine receptor 4 (CCR4) interaction-antagonistic 3-peperazinyl coumarin derivatives
05/11/2011CN101503405B Preparation of lyral Vc acetal
05/11/2011CN101180294B Pyran/dioxan derivatives and use thereof in liquid crystal media
05/05/2011WO2011051380A1 Polyketide molecules as anticancer agents
05/05/2011US20110105769 Novel Substance FKI-3864 and Method for Preparation Thereof
05/04/2011EP2316937A1 Dna encoding polypeptide involved in biosynthesis of herboxidiene
05/04/2011EP2316833A1 Process for the preparation of Cyclopamine analogue compounds
05/04/2011EP2316832A1 Cyclopamine analogues and methods of use thereof
05/04/2011EP2316831A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer
05/04/2011EP2316459A1 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 120